| Product Code: ETC8531720 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Angioedema Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Angioedema Market - Industry Life Cycle |
3.4 Netherlands Angioedema Market - Porter's Five Forces |
3.5 Netherlands Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Netherlands Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Netherlands Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Netherlands Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Netherlands Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Netherlands Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients |
4.2.2 Technological advancements in diagnosis and treatment of angioedema |
4.2.3 Growing prevalence of angioedema cases in the Netherlands |
4.3 Market Restraints |
4.3.1 High cost of treatment and medications for angioedema |
4.3.2 Limited access to specialized healthcare services for angioedema patients |
4.3.3 Stringent regulatory requirements for approval of new therapies |
5 Netherlands Angioedema Market Trends |
6 Netherlands Angioedema Market, By Types |
6.1 Netherlands Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Netherlands Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Netherlands Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Netherlands Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Netherlands Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Netherlands Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Netherlands Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Netherlands Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Netherlands Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Netherlands Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Netherlands Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Netherlands Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Netherlands Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Netherlands Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Netherlands Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Netherlands Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Netherlands Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Netherlands Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Netherlands Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Netherlands Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Netherlands Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Netherlands Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Netherlands Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Netherlands Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Netherlands Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Netherlands Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Netherlands Angioedema Market Import-Export Trade Statistics |
7.1 Netherlands Angioedema Market Export to Major Countries |
7.2 Netherlands Angioedema Market Imports from Major Countries |
8 Netherlands Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in angioedema diagnosis and treatment |
8.2 Adoption rate of new technologies for managing angioedema |
8.3 Percentage of angioedema patients receiving timely and appropriate care |
9 Netherlands Angioedema Market - Opportunity Assessment |
9.1 Netherlands Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Netherlands Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Netherlands Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Netherlands Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Netherlands Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Netherlands Angioedema Market - Competitive Landscape |
10.1 Netherlands Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here